16th Biennial European Conference: Author Index M

Author Index: M

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

• ONTOLOGY DRIVEN DECISION SUPPORT FOR EARLY DIAGNOSTIC RECOMMENDATIONS

Mackay, D.

• THE IMPACT OF THE ALCOHOL ACT ON ALCOHOL-RELATED HEALTH HARMS IN SCOTLAND

MacNeela, P.

• DOES MEDICAL EDUCATION PROVIDE A SHARED UNDERSTANDING OF THE TREATMENT THRESHOLD PROBABILITY FOR SUSPECTED STREP THROAT?

Madan, J.

• DISCRETE EVENT SIMULATION MODELLING TO ANALYSE INNOVATIONS IN CANCER PATHOLOGY SERVICES

Mahjoub, R.

• A NOVEL FRAMEWORK FOR OPTIMISING THE VALUE OF PRECISION MEDICINE TECHNOLGIES

• EVALUATING THE COST-EFFECTIVENESS OF MONITORING TESTS

Mahmoodi, N.

• DECISION AIDS' EFFICACY TO SUPPORT WOMEN'S FERTILITY PRESERVATION CHOICES BEFORE CANCER TREATMENT: AN ENVIRONMENTAL SCAN

Majeed, A.

• CLINICIAN-IDENTIFIED PRIORITIES FOR MEDICATION SAFETY IN PRIMARY CARE: A PRIORITIZE STUDY

Mak, C.

• ESTIMATING THE CLINICAL IMPACT AND COSTS OF IMPLEMENTING A POINT OF CARE TEST FOR INFLUENZA A/B AND RESPIRATORY SYNCYTIAL VIRUS ON AN ACUTE PAEDIATRIC HOSPITAL INPATIENT WARD

Mallett, S.

• PREDICTORS OF PATIENT PREFERENCES FOR WHOLE BODY MAGNETIC RESONANCE IMAGING COMPARED WITH STANDARD STAGING PATHWAYS FOR THE INVESTIGATION OF SYMPTOMS OF SUSPECTED COLORECTAL OR LUNG CANCER

Manca, A.

• AN OVERVIEW OF DIFFERENT MAPPING TECHNIQUES TO DERIVE HEALTH STATE UTILITY VALUES IN MULTIPLE MYELOMA FOR DECISION-ANALYTIC MODELING

• THE EFFECT OF THINKING TIME ON ATTRIBUTE NON-ATTENDANCE IN DISCRETE CHOICE EXPERIMENTS: AN EYE-TRACKING STUDY

• THE USE OF SPECIALTY TRAINING TO RETAIN DOCTORS IN MALAWI: A DISCRETE CHOICE EXPERIMENT

• ANALYSIS OF EYE GAZE PATTERNS AND DECISION-MAKING STRATEGIES DURING A DISCRETE CHOICE EXPERIMENT

Mannamparambil Chandrasekharan, G.

• ONTOLOGY DRIVEN DECISION SUPPORT FOR EARLY DIAGNOSTIC RECOMMENDATIONS

Mar, J.

• PROBABILISTIC SENSITIVITY ANALYSIS OF COST-EFFECTIVENESS ANALYSIS OF THE BREAST CANCER SCREENING PROGRAMME IN THE BASQUE COUNTRY: A MULTI-COHORT DISCRETE-EVENT SIMULATION MODEL

Marcella, S.

• BEZLOTOXUMAB IS ASSOCIATED WITH A REDUCTION IN CUMULATIVE HOSPITALIZED DAYS: ANALYSIS OF THE HOSPITALIZATION DATA FROM THE MODIFY I AND II CLINICAL TRIALS

• COST-EFFECTIVENESS OF BEZLOTOXUMAB+STANDARD OF CARE (SOC) VERSUS PLACEBO+SOC FOR THE PREVENTION OF RECURRENT CLOSTRIDIUM DIFFICILE INFECTION IN THE UNITED STATES

• BUDGET IMPACT OF FIDAXOMICIN COMPARED WITH VANCOMYCIN FOR THE TREATMENT OF CLOSTRIDIUM DIFFICILE ASSOCIATED DIARRHEA IN THE UNITED STATES

Marijnen, C.

• ONCOLOGIST AND PATIENT QUESTIONS DURING CONSULTATIONS ABOUT ADJUVANT CANCER TREATMENT: A SHARED DECISION-MAKING PERSPECTIVE

Marlow, L.

• A SYSTEMATIC REVIEW OF ETHNICITY-SPECIFIC FACTORS INFLUENCING CHILDHOOD IMMUNISATION DECISIONS AMONG BLACK AND ASIAN MINORITY ETHNIC GROUPS IN THE UK

Marsh, K.

• STRUCTURING BENEFIT-RISK MODELS IN PRESENCE OF NUMEROUS ADVERSE EVENTS: A CASE STUDY OF MULTIPLE SCLEROSIS

Marshall, P.

• THE DEVELOPMENT OF EXPERTISE IN NON-MEDICAL PERSONNEL INTERPRETING DIAGNOSTIC MAMMOGRAMS

Martin, S.

• THE EFFECT OF THINKING TIME ON ATTRIBUTE NON-ATTENDANCE IN DISCRETE CHOICE EXPERIMENTS: AN EYE-TRACKING STUDY

• ANALYSIS OF EYE GAZE PATTERNS AND DECISION-MAKING STRATEGIES DURING A DISCRETE CHOICE EXPERIMENT

McCabe, C.

• A NOVEL FRAMEWORK FOR OPTIMISING THE VALUE OF PRECISION MEDICINE TECHNOLGIES

• THE COST-EFFECTIVENESS MODEL OUTPUT TOOL

• MULTI-CRITERIA DECISION ANALYSIS: USEFUL, BUT NOT A SUITABLE REPLACEMENT FOR COST-EFFECTIVENESS ANALYSIS

• DECISION RULES FOR VALUE-BASED REIMBURSEMENT: MOVING ON FROM NET HEALTH BENEFIT

• TRANSFORMING THE COST-EFFECTIVENESS THRESHOLD INTO A 'VALUE THRESHOLD': INITIAL FINDINGS FROM A SIMULATION MODEL

• THE DETERMINANTS OF CHANGE IN THE COST-EFFECTIVENESS THRESHOLD

• RESOURCE ALLOCATION, VALUES AND EQUITY: MAINTAINING EQUITY IN THE FACE OF ANONYMITY

• EVALUATING THE COST-EFFECTIVENESS OF MONITORING TESTS

• PROBABILISTIC ONE-WAY SENSITIVITY ANALYSIS: A MODIFIED TORNADO DIAGRAM

• THE IMPACT OF THE ALCOHOL ACT ON ALCOHOL-RELATED HEALTH HARMS IN SCOTLAND

McDonald, K. M.

• ORAL ABSTRACTS: HEALTH SERVICES, OUTCOMES & POLICY RESEARCH

• UTILIZING ELECTRONIC HEALTH RECORD DOCUMENTATION TO MEASURE VALUE FOR PROSTATE CANCER CLINICAL CARE

McDowell, M.

• WHEN, WHY, AND FOR WHOM ARE NATURAL FREQUENCY FORMATS MOST EFFECTIVE? A META-ANALYSIS

McGregor, L.

• IMPROVING CANCER SCREENING INFORMATION: INSIGHTS FROM INDIVIDUAL DIFFERENCES IN INFORMATION PROCESSING

McIlfatrick, S.

• SYNTHESIS OF THREE DATA SOURCES TO DETERMINE INDEPENDENT VARIABLES IN AN ONLINE FACTORIAL SURVEY OF IMPLANTABLE CARDIOVERTER DEFIBRILLATOR DEACTIVATION DECISIONS

• UNDERSTANDING DOCTORS' PERCEPTIONS OF GOOD CLINICAL DECISION MAKING: AN INTERVIEW STUDY

Meier, P.

• CONTINGENCY MANAGEMENT IMPROVES COMPLETION OF HEPATITIS B VACCINATION IN THOSE ON TREATMENT FOR OPIATE DEPENDENCE: AN ECONOMIC EVALUATION

Melbye, H.

• INTER-OBSERVER AGREEMENT IN LUNG SOUND CLASSIFICATION AIDED BY VISUAL REPRESENTATION OF THE SOUNDS

Memon, S.

• THE EFFECT OF FECAL IMMUNOCHEMICAL TEST THRESHOLD ON COLORECTAL SCREENING OUTCOMES

Merker, V.

• IMPROVING DIAGNOSTIC DECISION MAKING FOR A RARE DISEASE: IDENTIFYING BARRIERS TO EARLY DIAGNOSIS OF SCHWANNOMATOSIS

Meterko, M.

• IMPROVING DIAGNOSTIC DECISION MAKING FOR A RARE DISEASE: IDENTIFYING BARRIERS TO EARLY DIAGNOSIS OF SCHWANNOMATOSIS

• CONTINGENCY MANAGEMENT IMPROVES COMPLETION OF HEPATITIS B VACCINATION IN THOSE ON TREATMENT FOR OPIATE DEPENDENCE: AN ECONOMIC EVALUATION

Miles, A.

• PREDICTORS OF PATIENT PREFERENCES FOR WHOLE BODY MAGNETIC RESONANCE IMAGING COMPARED WITH STANDARD STAGING PATHWAYS FOR THE INVESTIGATION OF SYMPTOMS OF SUSPECTED COLORECTAL OR LUNG CANCER

• THE EFFECT OF FECAL IMMUNOCHEMICAL TEST THRESHOLD ON COLORECTAL SCREENING OUTCOMES

Misirli, Y.

• DISCRETE CHOICE EXPERIMENT AS A TOOL TO CHANGE MEDICAL PRACTICE EFFICIENTLY: AN APPLICATION TO BASAL CELL CARCINOMA FOLLOW-UP VISITS

Misurski, D.

• LONG-TERM EFFECTIVENESS AND COST EFFECTIVENESS OF DIFFERENT ANTIVIRAL TREATMENTS FOR CHRONIC GENOTYPE-1 HCV INFECTION IN GERMANY INCLUDING OMBITASVIR/PARITAPREVIR/RITONAVIR AND DASABUVIR

• DIRECT ANTIVIRAL DRUGS FOR THE TREATMENT OF CHRONIC HEPATITIS C PATIENTS WITH GENOTYPE 1 OR 4 IN FRANCE - COST-EFFECTIVENESS OF OMBITASVIR/PARITAPREVIR/RITONAVIR WITH OR WITHOUT DASABUVIR BY FIBROSIS SUBGROUP

• BUDGET IMPACT ANALYSIS INCLUDING OMBITASVIR/PARITAPREVIR/RITONAVIR AND DASABUVIR FOR THE TREATMENT OF CHRONIC HEPATITIS C IN FRANCE

• THE ROLE OF TELEHOMECARE ON BLOOD PRESSURE CONTROL IN PATIENTS WITH HEART FAILURE AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN ONTARIO, CANADA

• THE COST-EFFECTIVENESS OF POINT-OF-CARE TROPONIN TESTING TO DIAGNOSE ACUTE CORONARY SYNDROME IN PRIMARY CARE

• MIXED METHOD PROGRAM EVALUATION OF THE TELEHOMECARE PROGRAM FOR PATIENTS WITH HEART FAILURE (HF) AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) IN ONTARIO, CANADA: QUALITATIVE STUDY

• SHARED DECISION MAKING IN ANTENATAL OBSTETRICS

Mooney, A.

• MAKING RESEARCH OUTPUTS ACCESSIBLE TO PEOPLE WITH KIDNEY DISEASE: IMPLEMENTING THE DIALYSIS DECISION AID BOOKLET

• EFFECTIVENESS OF DIETARY INTERVENTIONS IN CHRONIC KIDNEY DISEASE (CKD): A SYSTEMATIC REVIEW

Moons, C.

• ASSESSING CVD RISK AND BURDEN: DIFFERENCES IN PREDICTION MODELS AND POPULATIONS

• THE COST OF BEING WRONG: THE IMPACT OF PREDICTION UNCERTAINTY ON THE COST-EFFECTIVENESS OF RISK-STRATIFIED STRATEGIES

• FROM PREDICTED RISK TO PREDICTED BURDEN OF CARDIOVASCULAR DISEASE

• RETHINKING METHODS TO IDENTIFY OPTIMAL TREATMENT AND DIAGNOSTIC THRESHOLDS: EVALUATING RISK-BASED OUTCOMES IN CORONARY HEART DISEASE

Morris, H.

• EXTERNAL VALIDATION OF THE PATIENT MEASURE OF COLLABORATIVE GOAL SETTING: HOW DOES COLLABORATIVE GOAL SETTING IMPACT SELF-MANAGEMENT?

• THE IMPORTANCE OF A GOOD RELATIONSHIP WITH THE CLINICIAN: A CRITICAL FACTOR FOR COLLABORATIVE GOAL SETTING DISCUSSIONS ACCORDING TO PATIENTS

Morris, S.

• PREDICTORS OF PATIENT PREFERENCES FOR WHOLE BODY MAGNETIC RESONANCE IMAGING COMPARED WITH STANDARD STAGING PATHWAYS FOR THE INVESTIGATION OF SYMPTOMS OF SUSPECTED COLORECTAL OR LUNG CANCER

Morton, A.

• REVIEW OF THE HEALTH TECHNOLOGY ASSESSMENT PROCESS FOR ANTIBIOTICS IN SELECT EUROPEAN COUNTRIES

Mottini, A.

• TOLERANCE FOR AMBIGUITY AND STRESS: A STUDY AMONG ITALIAN PRACTICING PHYSICIANS

M�hlberger, N.

• LONG-TERM EFFECTIVENESS AND COST EFFECTIVENESS OF DIFFERENT ANTIVIRAL TREATMENTS FOR CHRONIC GENOTYPE-1 HCV INFECTION IN GERMANY INCLUDING OMBITASVIR/PARITAPREVIR/RITONAVIR AND DASABUVIR

• DIRECT ANTIVIRAL DRUGS FOR THE TREATMENT OF CHRONIC HEPATITIS C PATIENTS WITH GENOTYPE 1 OR 4 IN FRANCE - COST-EFFECTIVENESS OF OMBITASVIR/PARITAPREVIR/RITONAVIR WITH OR WITHOUT DASABUVIR BY FIBROSIS SUBGROUP

• THE BENEFIT-HARM BALANCE OF PROSTATE CANCER SCREENING IN MEN WITH AVERAGE AND ELEVATED FAMILIAL RISK � PREDICTIONS OF THE ONCOTYROL PROSTATE CANCER OUTCOME AND POLICY MODEL

Munson, S.

• DOMINANT ASPIRIN THERAPY STRATEGY ELIMINATES ROLE FOR IMAGING SCREENING/WARFARIN THERAPY FOR STROKE PREVENTION IN MODEL OF ASYMPTOMATIC BLUNT NECK TRAUMA

Murchie, P.

• SYMPOSIUM: THE DISCOVERY PROGRAMME AND ITS INFLUENCE ON EARLY CANCER DIAGNOSIS

Murphy, J.

• EVALUATING PREDICTED RESOURCE USE, COST AND QUALITY OF LIFE OUTCOMES OF COLORECTAL CANCER SCREENING WITH THE FAECAL IMMUNOCHEMICAL TEST IN ENGLAND USING ECONOMIC MODELLING

• DECISION ANALYTIC GUIDANCE OF DIAGNOSTIC TEST EVALUATION OBVIATES THE REQUIREMENT FOR RANDOMIZED TRIALS

Muula, A.

• THE USE OF SPECIALTY TRAINING TO RETAIN DOCTORS IN MALAWI: A DISCRETE CHOICE EXPERIMENT

Myers, M.

• INCREASING HIGH-VALUE VENOUS THROMBOEMBOLISM PROPHYLAXIS: A WIN-WIN SITUATION

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z